"identifier","description","label","id","uuid:ID","name","text","instanceType"
"1","The study age criterion","","EligibilityCriterion_1","9b07fa1a-ba68-42f6-be35-556bb02ad43c","Age Criteria","Subjects shall be between [min_age] and [max_age]","EligibilityCriterion"
"2","The study population criterion","","EligibilityCriterion_2","50b8b068-d88a-4718-b265-d889d94a7e92","Pop Criteria","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","EligibilityCriterion"
"3","The study diagnosis criterion","","EligibilityCriterion_3","b97cd1ba-2b3c-4c88-9649-ec7ff02356cf","Diag Criteria","[Activity1] score of 10 to 23","EligibilityCriterion"
"9","The previous xanomeline TTS criterion","","EligibilityCriterion_4","01bacf5a-d71b-4a05-a943-43bf806bbe42","Previous Criteria","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","EligibilityCriterion"
